Activity Provided By:

ACHL

Participatory Medicine in IPF: Bridging Communication Gaps Between Clinicians, Patients and Caregivers

Overview / Abstract:	This educational activity consists of two, 30-minute digital classroom activities designed to engage clinicians that treat patients with idiopathic pulmonary fibrosis (IPF). A patient education activity has been developed as well to help bridge the communication gap between clinicians and patients, while providing an educational resource developed specific for the patient and caregiver. Upon completion of this activity, participants will be able to: •Discuss the impact of IPF on patient quality of life over the disease course •Evaluate the efficacy and safety data for pharmacotherapies used to treat IPF •Outline strategies for managing potential side effects across diverse patient populations •Counsel IPF patients and their families on pharmacologic and nonpharmacologic approaches and support strategies •Describe benefits of a multidisciplinary approach over the course of IPF
Expiration	Dec 29, 2017
Discipline(s)	Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME, Respiratory Therapy CE
Format	Online, Webinar / Webcast / Video
Credits / Hours	1
Accreditation	ACCME
Is This Activity Certified for "Live" Credit?	YES
Presenters / Authors / Faculty	Kevin R. Flaherty, MD, MS Professor of Medicine Pulmonary/Critical Care University of Michigan Ann Arbor, MI Imre Noth, MD Professor of Medicine Director, Bronchoscopy Director, Interstitial Lung Disease Program The University of Chicago Medicine Chicago, IL Amy L. Olson, MD, MSPH Assistant Professor Division of Pulmonary, Critical Care and Sleep Medicine National Jewish Health Denver, CO
Sponsors / Supporters / Grant Providers	This activity is supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Genentech, Inc.
Keywords / Search Terms	ACHL ACHL, IPF, BI, Genentech, CME, CME/CE, Idiopathic pulmonary fibrosis, ArcheMedX, myCME, Imre Noth, Kevin Flaherty, Amy Olson, interstitial lung disease, pulmonology, respiratory therapy, pirfenidone, nintedanib, ProPatient, PFF, Pulmonary Fibrosis, Pulmonary Fibrosis Foundation Free CE CME Live CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map